angiotensin ii has been researched along with ks370g in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, HL; Chuang, CF; Chuang, ST; Kuo, YH; Su, MJ; Weng, YC | 1 |
| Chuang, ST; Kuo, YH; Su, MJ | 1 |
2 other study(ies) available for angiotensin ii and ks370g
| Article | Year |
|---|---|
KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
Topics: Actins; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Caffeic Acids; Cardiotonic Agents; Collagen; Constriction; Extracellular Signal-Regulated MAP Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Ventricles; Hypertrophy; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred ICR; Myocytes, Cardiac; Phosphoproteins; Pressure; Proto-Oncogene Proteins c-akt; Time Factors | 2012 |
KS370G, a caffeamide derivative, attenuates unilateral ureteral obstruction-induced renal fibrosis by the reduction of inflammation and oxidative stress in mice.
Topics: Angiotensin II; Animals; Biomarkers; Caffeic Acids; Catalase; Cell Adhesion Molecules; Chemokines; Collagen Type I; Cytoprotection; Fibronectins; Fibrosis; Gene Expression Regulation; Inflammation; Kidney; Lipid Peroxidation; Male; Mice; Oxidative Stress; Smad3 Protein; Superoxide Dismutase; Transforming Growth Factor beta1; Ureteral Obstruction | 2015 |